We used the R/ATA system to identify Pa as a factor that can reduce FGFR3 protein abundance by directly shortening its half-life, which attenuates FGFR3 downstream signaling in both cancer cells and chondrocytes. This evidence concerns the gene FGFR3 and cancer.